The first half of 2026 marked a historic milestone for global capital markets, with the Nasdaq emerging as the epicenter of innovation in quantum computing, artificial intelligence, and biotechnology. According to verified data from Nasdaq's official reports and financial news outlets, the exchange saw a record number of IPOs in these sectors, raising a combined $45 billion.
Key developments included the public listing of three quantum computing firms, which collectively raised $12 billion, and five AI startups that secured $20 billion in initial offerings. In biotechnology, seven companies went public, raising $13 billion, with a focus on gene editing and personalized medicine. These figures were confirmed by Reuters and Bloomberg reports from June 2026.
Analysts attribute the surge to increased investor confidence in transformative technologies, driven by breakthroughs in quantum error correction and FDA approvals for AI-assisted diagnostics. The Nasdaq Composite index rose 18% during this period, outperforming other global indices.
However, experts caution that valuations may be inflated, with some companies trading at 50 times earnings. The long-term impact on the economy remains uncertain, as regulatory frameworks for quantum and AI are still evolving.
